Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Pratt

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|May 28, 2008
South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patientsChaminda Gunawardana, Belinda Austen, Judith E Powell, et al.
British Journal of Haematology|September 27, 2003
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemiaJane Starczynski, Chris Pepper, Guy Pratt, et al.
Leukemia & Lymphoma|July 6, 2014
Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomasRachel E Hayden, Racha Kussaibati, Laura M Cronin, et al.
British Journal of Haematology|February 23, 2024
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice PaperDaniel Hughes, Kwee Yong, Karthik Ramasamy, et al.
Immunity & Ageing : I & A|January 7, 2016
Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 yearsHelen M Parry, Jianmin Zuo, Guido Frumento, et al.
British Journal of Haematology|May 28, 2008
Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patientThet Thet Lin, Saman Hewamana, Rachel Ward, et al.
Journal of Proteome Research|July 2, 2014
Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemiaSuliman A Alsagaby, Sanjay Khanna, Keith W Hart, et al.
British Journal of Haematology|November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemiaGuy Pratt, Stephen Harding, Roger Holder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemiaSaman Hewamana, Thet Thet Lin, Clare Rowntree, et al.
British Journal of Haematology|August 16, 2005
Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survivalRichard Lovell, Janet A Dunn, Gulnaz Begum, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|May 28, 2008
South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patientsChaminda Gunawardana, Belinda Austen, Judith E Powell, et al.
British Journal of Haematology|September 27, 2003
The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemiaJane Starczynski, Chris Pepper, Guy Pratt, et al.
Leukemia & Lymphoma|July 6, 2014
Bezafibrate and medroxyprogesterone acetate target resting and CD40L-stimulated primary marginal zone lymphoma and show promise in indolent B-cell non-Hodgkin lymphomasRachel E Hayden, Racha Kussaibati, Laura M Cronin, et al.
British Journal of Haematology|February 23, 2024
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice PaperDaniel Hughes, Kwee Yong, Karthik Ramasamy, et al.
Immunity & Ageing : I & A|January 7, 2016
Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 yearsHelen M Parry, Jianmin Zuo, Guido Frumento, et al.
British Journal of Haematology|May 28, 2008
Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patientThet Thet Lin, Saman Hewamana, Rachel Ward, et al.
Journal of Proteome Research|July 2, 2014
Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemiaSuliman A Alsagaby, Sanjay Khanna, Keith W Hart, et al.
British Journal of Haematology|November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemiaGuy Pratt, Stephen Harding, Roger Holder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemiaSaman Hewamana, Thet Thet Lin, Clare Rowntree, et al.
British Journal of Haematology|August 16, 2005
Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survivalRichard Lovell, Janet A Dunn, Gulnaz Begum, et al.
Pageof 14